[8-K] Viridian Therapeutics, Inc. Reports Material Event

Rhea-AI Filing Summary

News Corporation filed its Form 10-K for the fiscal year ended 30 Jun 2025. Foxtel was sold on 2 Apr 2025; all related results are now reported as discontinued operations, eliminating the former Subscription Video Services segment.

Continuing operations – FY-25 revenue & EBITDA (US$ mn)

• Dow Jones: $2,331 revenue / $588 EBITDA
• Digital Real Estate Services: $1,802 / $601
• Book Publishing: $2,149 / $296
• News Media: $2,170 / $153
• Other: $0 / –$223

Dow Jones consumer metrics for the Mar-Jun quarter show 4.126 m digital-only WSJ subscriptions and 6.261 m total consumer subscriptions (print + digital). REA Group’s Australian portal averaged 132 m monthly visits; Realtor.com averaged 72 m monthly unique users in Q4. News UK reports 640 k digital subscribers for The Times/Sunday Times; News Australia counted 993 k digital subscribers across mastheads.

As of 1 Aug 2025 the company had 376.4 m Class A and 188.5 m Class B shares outstanding. Market value held by non-affiliates on 27 Dec 2024 totalled roughly $14 bn.

Positive

• Completion of Foxtel sale simplifies the business and removes a non-core asset.
• High-margin segments Dow Jones and Digital Real Estate generated $1.2 bn of the $1.4 bn total segment EBITDA.
• Digital subscriber base reached 6.3 m across Dow Jones consumer products, supporting recurring revenue.

Negative

• Other segment posted a $223 m EBITDA loss, weighing on consolidated profitability.
• News Media EBITDA margin was only ~7%, illustrating ongoing print and advertising pressure.
• Regulatory and competitive risks from data-privacy laws, AI platforms and alternative media are identified throughout the filing.

Insights

Financial Analyst

TL;DR: Solid segment EBITDA, Foxtel exit streamlines portfolio; limited profit detail restricts earnings view.

The filing highlights an $8.5 bn continuing-revenue base with EBITDA concentration in Dow Jones and Digital Real Estate (combined 59% of segment EBITDA). The Foxtel divestiture removes a lower-growth pay-TV asset, sharpening focus on digital subscriptions and property classifieds. However, the Other segment’s –$223 m drag and absence of net income, cash-flow or leverage data leave questions on overall profitability and capital allocation.

Media-Industry Specialist

TL;DR: Digital scale growing—6.3 m consumer subs plus AI licensing prospects—but traditional news units still margin-light.

Dow Jones posted 25% EBITDA margin, leveraging 6 m subs and AI licensing avenues. REA and Move deliver strong traffic leadership, supporting $601 m EBITDA. Book Publishing remained profitable despite market softness. News Media’s $153 m EBITDA on $2.17 bn revenue underscores print headwinds even with 60% U.K. reach. Competitive pressures from tech platforms and evolving privacy rules remain material.

Viridian Therapeutics, Inc.\DE false 0001590750 0001590750 2025-08-06 2025-08-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 6, 2025

VIRIDIAN THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-36483		47-1187261
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

221 Crescent Street, Suite 103A Waltham, MA		02453
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (617) 272-4600

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value		VRDN		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On August 6, 2025, Viridian Therapeutics, Inc. issued a press release reporting financial results for the quarter ended June 30, 2025.

The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this Current Report on Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1		Press release, dated August 6, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				Viridian Therapeutics, Inc.
Date: August 6, 2025				By:		/s/ Stephen Mahoney
						Stephen Mahoney
						President and Chief Executive Officer

FAQ

How much revenue did News Corp (NWSA) generate in FY-2025 by segment?

Dow Jones $2.33 bn, Digital Real Estate $1.80 bn, Book Publishing $2.15 bn, News Media $2.17 bn, Other $0.

When did News Corp complete the sale of Foxtel?

The Foxtel sale closed on 2 Apr 2025 and is treated as a discontinued operation.

What is the size of The Wall Street Journal’s digital-only subscriber base?

4.126 million digital-only subscriptions on average during Mar-Jun 2025.

How many shares of NWSA and NWS are outstanding?

As of 1 Aug 2025, 376.4 m Class A (NWSA) and 188.5 m Class B (NWS) shares were outstanding.

Which segments produced the highest EBITDA in FY-2025?

Digital Real Estate Services ($601 m) and Dow Jones ($588 m) led segment EBITDA.

What market share do News UK titles hold?

Collectively, The Sun, The Times and The Sunday Times represented about one-third of U.K. national newspaper sales.